ORCHPHARMA

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - I (13).

Orchid Pharma Ltd.

NSE: ORCHPHARMA

BSE: 524372

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

965.80+19.3 (+2.04%)

8 Sep, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

28.6 / 100

Value Score

12.6 / 100

Price Momentum Score

87.5 / 100

QVM Score

31.3 / 100

Key Metrics

Market Cap

5783.69

P/E (TTM)

721.13

P/B

4.49

P/S (TTM)

6.14

EV/EBITDA

170.03

CAPE (5Y)

117.90

ROE (TTM)

1.61

ROCE (TTM)

0.37

ROA (TTM)

1.14

Avg 3Y ROE

5.99

Earnings 3Y CAGR

-40.93

Sales 3Y CAGR

9.50

Sales 5Y CAGR

17.37

Debt/Equity

0.28

Consensus TP

1061.00

Strong Buy %

Promoter Holding

69.84

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Orchid Pharma Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 87.5 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

87.5 / 100

Analysts have been raising forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has increased by 7.14% in the last 3 months, indicating earnings momentum

What is Earnings upgrade (3M)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.28 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.14 in the last 1 year

What is Debt to Equity?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 721.13 indicates that the stock is expensive on a standalone basis and is at a 2169.13% premium to industry median P/E

What is P/E Ratio?

Median: 31.78

Value 721.13

-0.96721.13

Low and declining ROE

The company reported low ROE of 1.61% for 12-month ended 30 Jun 2026 and ROE declined by -657 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of 0.7% for 12-month ended 30 Jun 2026 and operating margin declined by -684 bps from 1 year ago

What is Operating profit margin?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -79.39% for 12-month ended 30 Jun 2026 and the growth was 86.59 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Moderate revenue growth and in line with median growth of industry

The company delivered moderate revenue growth of 10.83% for 12-month ended 30 Jun 2026 and the growth was 0.24 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 10.83

-99.6111701.8

Company's earnings are of moderate quality

Earnings quality score of 66.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

66.0 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Orchid Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Orchid Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Orchid Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	26.68	26.68	26.68	98.07	98.07	90.00	90.00	90.00	90.00	89.96	89.96	89.96	89.96	72.40	72.40	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84
Indian Promoter	26.68	26.68	26.68	98.07	98.07	90.00	90.00	90.00	90.00	89.96	89.96	89.96	89.96	72.40	72.40	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	4.52	4.52	4.51	1.27	1.04	5.50	5.18	5.17	4.62	4.49	4.35	4.80	3.43	22.07	20.55	18.64	19.69	20.35	20.23	21.52	22.79	20.83	20.60	20.56	21.12	21.56
Mutual Funds / UTI	0.00	0.00	0.00	0.00	0.00	2.45	2.45	2.45	2.45	2.45	2.45	2.45	2.45	9.78	9.76	10.40	15.18	16.91	16.78	17.46	18.79	18.58	18.04	18.01	19.43	19.93
FI/Bank/Insurance	3.68	3.68	3.68	1.23	1.00	1.00	0.90	0.90	0.52	0.52	0.53	0.29	0.14	0.17	0.13	2.57	1.05	0.98	0.93	0.95	0.66	0.20	0.20	0.19	0.15	0.13
Govt	-	-	-	-	-	-	0.04	0.04	0.04	0.04	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.80	0.80	0.80	0.04	0.04	1.79	1.79	1.78	1.61	1.48	1.37	0.86	0.81	0.45	8.08	4.14	1.96	1.42	1.94	2.53	2.69	1.39	1.56	1.17	0.87	0.80
Other Institutions	0.04	0.04	0.04	0.01	0.00	0.26	0.00	0.00	0.00	0.00	0.00	1.20	0.03	11.66	2.58	1.54	1.50	1.04	0.59	0.59	0.65	0.65	0.80	1.19	0.66	0.69
Non-Institution	68.80	68.80	68.81	0.66	0.89	4.51	4.83	4.84	5.39	5.55	5.68	5.23	6.60	5.53	7.06	11.53	10.47	9.81	9.93	8.64	7.38	9.34	9.57	9.60	9.05	8.61
Bodies Corporate	5.31	5.31	5.23	0.05	0.04	1.38	1.82	1.62	0.68	0.57	1.82	1.49	2.90	2.22	2.03	2.57	1.83	1.70	1.52	1.42	1.34	1.49	1.58	1.87	1.60	1.58
Others (incl. Retail) No. of shareholders	63.49 84,185	63.49 84,182	63.58 30,763	0.61 30,279	0.85 29,920	3.13 32,968	3.01 34,414	3.22 33,178	4.71 33,347	4.98 33,335	3.86 32,366	3.74 30,550	3.70 29,187	3.31 28,764	5.03 28,827	8.96 36,497	8.64 36,269	8.11 34,219	8.41 35,839	7.22 33,625	6.04 33,825	7.85 39,391	7.99 37,708	7.73 35,256	7.45 34,699	7.03 33,024

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Orchid Pharma Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
DHANUKA LABORATORIES LIMITED Promoter	November-2023	Off Market (Disposal) 29th Nov 2023	72.40 %	₹ 571.28	13.00 lac	₹ 74.27 cr

Corporate Actions

History of Orchid Pharma Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Others
Ex-date: 25th Jul 2019Announced on: 17th Jul 2019
Change in shares from 88964327 to 408164.
Dividend₹ 3/share
Record date: 14th Sep 2012Ex-date: 13th Sep 2012
Announced on: 14th May 2012
Dividend₹ 3/share
Record date: 20th Jul 2011Ex-date: 19th Jul 2011
Announced on: 18th May 2011
Dividend₹ 10/share
Record date: 13th Jul 2010Ex-date: 12th Jul 2010
Announced on: 27th May 2010
Dividend₹ 1/share
Record date: 18th Sep 2009Ex-date: 17th Sep 2009
Announced on: 29th Jun 2009

Company Profile

Overview of Orchid Pharma Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of formulations and active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-infl...

Key personnel

Shri. Sunil Kumar Gupta

Chief Financial Officer

Mr. Kapil Dayya

Compliance Officer, Company Secretary

Dr. R. J. Sarangdhar

Vice President, Unit Head - API and FDF

Dr. Srinivasan S

Head - CTD and IPM

Shri. Ram Gopal AgarwalD

Non-Executive Non-Independent Chairman of the Board

Shri. Manish DhanukaD

Managing Director, Executive Director

Shri. Mridul DhanukaD

Whole Time Director

Shri. Manoj Kumar GoyalD

Non-Executive Independent Director

View all

Incorporated on

01 Jul 1992

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

06 Sep 1993

Free Float

2,44,62,281

Website

https://www.orchidpharma.com/

Phone no.

+914425211000

Address

15th Floor, Tower-1, DLF Corporate Greens, Sector 74A, Narsinghpur, GURGAON, 122004, India

Frequently Asked Questions

What is the current share price of Orchid Pharma Ltd.?

The current share price of Orchid Pharma Ltd. is ₹ 965.80 as of 8 Sep 2026.

What is the market capitalisation of Orchid Pharma Ltd.?

The market capitalisation of Orchid Pharma Ltd. stands at ₹ 5,783.69 Cr.

What is the PE ratio of Orchid Pharma Ltd.?

The Price-to-Earnings (PE) ratio of Orchid Pharma Ltd. is 721.13 as of the latest trailing twelve months data.

What is the ROE and ROCE of Orchid Pharma Ltd.?

Orchid Pharma Ltd. has a Return on Equity (ROE) of 1.61% and a Return on Capital Employed (ROCE) of 0.37% as per the latest financial reports.

What is the 52-week high and low of Orchid Pharma Ltd.?

The 52-week high of Orchid Pharma Ltd. is - and the 52-week low is -.

What is the dividend yield of Orchid Pharma Ltd.?

The dividend yield of Orchid Pharma Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Orchid Pharma Ltd.?

Foreign Institutional Investors (FII) hold 0.80%, Domestic Institutional Investors (DII) hold 20.06% and retail/public investors hold 7.03% of Orchid Pharma Ltd. shares.

What sector does Orchid Pharma Ltd. belong to?

Orchid Pharma Ltd. operates in the Healthcare sector.

What is the beta of Orchid Pharma Ltd.?

The beta of Orchid Pharma Ltd. is 1.16, indicating its price volatility relative to the broader market. Over the past 1 year, Orchid Pharma Ltd. has delivered an absolute return of 31.36%.

What is the RSI of Orchid Pharma Ltd.?

The 14-day Relative Strength Index (RSI) of Orchid Pharma Ltd. is 47.51, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Orchid Pharma Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Orchid Pharma Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile